16/02/2026 06:00
|
Medical, Health & Aged Care
ALYFTREK® is now reimbursed for Australians with cystic fibrosis (CF) aged 6 years and older with at least one responsive mutation –
Approximately 3,200 Australians living with CF are now able to...